Home

Cardiology

Diabetes/Endocrinology

General Medicine

HIV/Infectious Diseases

Neurology

Oncology

Pulmonary Medicine

Coverage from the

American Society for Clinical Oncology (ASCO) 2021

Read clinically focused news coverage of key developments from ASCO 2021

Conference Report

ASCO 2021 — Proteasome inhibitor marizomib no better than standard of care in glioblastoma

16 June 2021

Emergency Medicine

Head and Neck Cancer

Neurology

Social Determinants of Health

Stroke/Cerebrovascular Disease

Vaccination

Conference Report

ASCO 2021 — VISION, a phase 3 study of lutetium-PSMA-617 in patients with metastatic castration-resistant prostate cancer

16 June 2021

Biologic

Nurses

Prostate Cancer

Conference Report

ASCO 2021 — TOTEM study excludes benefit of highly intensive follow-up in endometrial cancer “with high certainty”

15 June 2021

Obesity and Weight Management

Social Determinants of Health

Vaccination

Women's Health

Wound Management

Continue Reading Below

Conference Report

ASCO 2021 — First results of trial on first-line treatment of hormone-dependent prostate cancer

15 June 2021

Acute Coronary Syndromes (ACS)

Antibiotics

Atrial Fibrillation

Cardiology

Cardiovascular Risk Reduction

Obesity and Weight Management

Pain Management

Prostate Cancer

Sleep Disorders

Social Determinants of Health

Vaccination

Wound Management

Conference Report

ASCO 2021 — Lessons learnt from the COVID-19 pandemic, toward a novel oncology

15 June 2021

Antibiotics

COVID-19

General Medicine

HIV/Infectious Diseases

HPV and Cervical Cancer

Headache

Influenza

Migraine

Obesity and Weight Management

Pain Management

Sepsis

Sleep Disorders

Social Determinants of Health

Vaccination

Wound Management

Conference Report

ASCO 2021 — OUTBACK study says additional chemo doesn’t improve survival in cervical cancer

14 June 2021

Contraception

Emergency Medicine

HPV and Cervical Cancer

Social Determinants of Health

Vaccination

Women's Health

Conference Report

ASCO 2021 — Immunotherapy advances treatment of nasopharyngeal carcinoma

14 June 2021

Obesity and Weight Management

Conference Report

ASCO 2021 — Expert commentary: fine-tuning of induction therapy for Ewing sarcoma

14 June 2021

Autism

Fracture

Conference Report

ASCO 2021 — Is it safe to take a break from CRC treatments?

11 June 2021

Colorectal Cancer

Emergency Medicine

Gastroenterology

Inflammatory Bowel Disease

Social Determinants of Health

Vaccination

Conference Report

ASCO 2021 — Actively working on the end, from the beginning

11 June 2021

Antibiotics

Headache

Migraine

Obesity and Weight Management

Conference Report

ASCO 2021 — Survival benefit with sotorasib in NSCLC with KRAS p.G12C mutations

11 June 2021

Conference Report

ASCO 2021 — Rare tumors, common mutations: ALK as a treatment target for adult-onset neuroblastoma

10 June 2021

Social Determinants of Health

Stroke/Cerebrovascular Disease

Vaccination

Conference Report

ASCO 2021 — Immunotherapy to fill the adjuvant treatment gap in kidney cancer

10 June 2021

Biologic

Conference Report

ASCO 2021 — Big gains from immunotherapy in hard-to-treat oesophageal cancers

9 June 2021

Inflammatory Bowel Disease

Migraine

Noncolorectal Gastrointestinal Cancer

Obesity and Weight Management

Continue Reading Below

ASCO 2021 — Proteasome inhibitor marizomib no better than standard of care in glioblastoma

ASCO 2021 — VISION, a phase 3 study of lutetium-PSMA-617 in patients with metastatic castration-resistant prostate cancer

ASCO 2021 — TOTEM study excludes benefit of highly intensive follow-up in endometrial cancer “with high certainty”

ASCO 2021 — First results of trial on first-line treatment of hormone-dependent prostate cancer

ASCO 2021 — Lessons learnt from the COVID-19 pandemic, toward a novel oncology

ASCO 2021 — OUTBACK study says additional chemo doesn’t improve survival in cervical cancer

ASCO 2021 — Immunotherapy advances treatment of nasopharyngeal carcinoma

ASCO 2021 — Expert commentary: fine-tuning of induction therapy for Ewing sarcoma

ASCO 2021 — Is it safe to take a break from CRC treatments?

ASCO 2021 — Actively working on the end, from the beginning

ASCO 2021 — Survival benefit with sotorasib in NSCLC with KRAS p.G12C mutations

ASCO 2021 — Rare tumors, common mutations: ALK as a treatment target for adult-onset neuroblastoma

ASCO 2021 — Immunotherapy to fill the adjuvant treatment gap in kidney cancer

ASCO 2021 — Big gains from immunotherapy in hard-to-treat oesophageal cancers

Conferences

International Congress of the European Respiratory Society (ERS) 2023

European Society of Cardiology (ESC) 2023

European Academy of Neurology (EAN) 2023

American Society of Clinical Oncology (ASCO) 2023

European Alliance of Associations for Rheumatology (EULAR) 2023

European Association for the Study of Diabetes (EASD) - 2022

Immuno-Oncology Congress (ESMO) 2022

International Congress of the European Respiratory Society (ERS) 2022

European Society of Cardiology (ESC) 2022

International AIDS Society (IAS) Conference 2022